Literature DB >> 21888680

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome.

Richard A C Hughes1.   

Abstract

A new randomised controlled trial suggested that plasma exchange hastened removal from the ventilator in mechanically ventilated children with Guillain-Barré syndrome compared with intravenous immunoglobulin. Two larger trials in adults showed the opposite result.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21888680      PMCID： PMC3387608          DOI： 10.1186/cc10312

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


  6 in total

1.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.

Authors:  F G van der Meché; P I Schmitz
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

2.  Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors: 
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

Review 3.  Plasma exchange for Guillain-Barré syndrome.

Authors:  J C Raphaël; S Chevret; R A Hughes; D Annane
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 4.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  Richard Ac Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2010-06-16

Review 5.  Immunotherapy for Guillain-Barré syndrome: a systematic review.

Authors:  Richard A C Hughes; Anthony V Swan; Jean-Claude Raphaël; Djillali Annane; Rinske van Koningsveld; Pieter A van Doorn
Journal:  Brain       Date:  2007-03-02       Impact factor: 13.501

6.  Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study.

Authors:  Mohammed A El-Bayoumi; Ahmed M El-Refaey; Alaa M Abdelkader; Mohamed M A El-Assmy; Angi A Alwakeel; Hanem M El-Tahan
Journal:  Crit Care       Date:  2011-07-11       Impact factor: 9.097
  6 in total
  1 in total

1.  Treatment options in paraneoplastic disorders of the peripheral nervous system.

Authors:  Jean-Christophe Antoine; Jean-Philippe Camdessanché
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.